124 related articles for article (PubMed ID: 15971449)
1. Clinical trials referral resource.
Wright JJ; Zerivitz K; Gravell A
Oncology (Williston Park); 2005 May; 19(6):722, 725-6, 728 passim. PubMed ID: 15971449
[No Abstract] [Full Text] [Related]
2. BAY-43-9006 Bayer/Onyx.
Lee JT; McCubrey JA
Curr Opin Investig Drugs; 2003 Jun; 4(6):757-63. PubMed ID: 12901237
[TBL] [Abstract][Full Text] [Related]
3. [Clinical results of Nexavar for the treatment of kidney cancer].
Escudier B
Prog Urol; 2007 Feb; 17(1 Suppl 1):150-3. PubMed ID: 17571640
[No Abstract] [Full Text] [Related]
4. FDA approves sorafenib for patients with inoperable liver cancer.
Lang L
Gastroenterology; 2008 Feb; 134(2):379. PubMed ID: 18242200
[No Abstract] [Full Text] [Related]
5. Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
Kelley RK; Venook AP
J Clin Oncol; 2008 Dec; 26(36):5845-8. PubMed ID: 19029408
[No Abstract] [Full Text] [Related]
6. Treatment for advanced kidney cancer.
FDA Consum; 2006; 40(2):3. PubMed ID: 16673450
[No Abstract] [Full Text] [Related]
7. Sorafenib: delivering a targeted drug to the right targets.
Flaherty KT
Expert Rev Anticancer Ther; 2007 May; 7(5):617-26. PubMed ID: 17492926
[TBL] [Abstract][Full Text] [Related]
8. Molecule of the month. Sorafenib.
Drug News Perspect; 2006 Mar; 19(2):119. PubMed ID: 16628266
[No Abstract] [Full Text] [Related]
9. Drug approval triggers debate on future direction for cancer treatments.
Frantz S
Nat Rev Drug Discov; 2006 Feb; 5(2):91. PubMed ID: 16521324
[No Abstract] [Full Text] [Related]
10. Clinical trials referral resource. Clinical trials using bryostatin-1.
Pluda JM; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 May; 10(5):740-2. PubMed ID: 8738829
[No Abstract] [Full Text] [Related]
11. Clinical trials referral resource. Current clinical trials of BAY 43-9006, Part 1.
Wright JJ; Zerivitz K; Gravell A
Oncology (Williston Park); 2005 Apr; 19(4):499-502. PubMed ID: 15934518
[No Abstract] [Full Text] [Related]
12. A tale of two drugs.
Nat Rev Drug Discov; 2006 Oct; 5(10):803. PubMed ID: 17078168
[No Abstract] [Full Text] [Related]
13. [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].
Boige V; Barbare JC; Rosmorduc O;
Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):3-7. PubMed ID: 18341970
[No Abstract] [Full Text] [Related]
14. Clinical trials referral resource. Clinical trials using thalidomide.
Phillips PH; Pluda JM; Cheson BD
Oncology (Williston Park); 1996 Oct; 10(10):1498, 1501. PubMed ID: 8905842
[No Abstract] [Full Text] [Related]
15. Searching for the Achilles' heel of melanoma cells: new treatment modalities.
Melnikova VO; Bar-Eli M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):505-6. PubMed ID: 18713130
[No Abstract] [Full Text] [Related]
16. Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.
Ivy SP; Blatner G; Cheson BD
Oncology (Williston Park); 1999 Aug; 13(8):1116-8. PubMed ID: 10499245
[No Abstract] [Full Text] [Related]
17. Clinical trials referral resource. Clinical trials of MGI-114.
Murgo A; Cannon DJ; Blatner G; Cheson BD
Oncology (Williston Park); 1999 Feb; 13(2):233, 237-8. PubMed ID: 10079472
[No Abstract] [Full Text] [Related]
18. Clinical trials referral resource. Clinical trials using edatrexate.
Cheson BD; Sorenson JM; Phillips PH
Oncology (Williston Park); 1993 Jul; 7(7):33-4. PubMed ID: 8347459
[No Abstract] [Full Text] [Related]
19. Clinical trials referral resource. Clinical trials of dolastatin-10.
Wright JJ; Blatner G; Cheson BD
Oncology (Williston Park); 1999 Jan; 13(1):68-70, 75. PubMed ID: 10027199
[No Abstract] [Full Text] [Related]
20. Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.
Ivy SP; Blatner G; Cheson BD
Oncology (Williston Park); 1999 Jul; 13(7):966, 969-70. PubMed ID: 10442343
[No Abstract] [Full Text] [Related]
[Next] [New Search]